Thymomas. Current Experience and Future Directions in Therapy

Overview

Journal Drugs

Specialty Pharmacology

Date 1993 Apr 1

PMID 7684669

Authors

P J Loehrer

Affiliations

Soon will be listed here.

References

Michon J, Caligiuri M, Hazanow S, Levine H, Schlossman S, Ritz J . Induction of natural killer effectors from human thymus with recombinant IL-2. J Immunol. 1988; 140(10):3660-7. View

Curran Jr W, Kornstein M, Brooks J, Turrisi 3rd A . Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988; 6(11):1722-7. DOI: 10.1200/JCO.1988.6.11.1722. View

Nabholz M, MacDonald H . Cytolytic T lymphocytes. Annu Rev Immunol. 1983; 1:273-306. DOI: 10.1146/annurev.iy.01.040183.001421. View

Berthaud P, Le Chevalier T, Tursz T . Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet. 1990; 335(8705):1590. DOI: 10.1016/0140-6736(90)91415-7. View

Penn C, HOPE-STONE H . The role of radiotherapy in the management of malignant thymoma. Br J Surg. 1972; 59(7):533-9. DOI: 10.1002/bjs.1800590708. View

Loehrer Sr P, Lauer R, Roth B, Williams S, Kalasinski L, Einhorn L . Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med. 1988; 109(7):540-6. DOI: 10.7326/0003-4819-109-7-540. View

Butler W, Diehl L, Taylor H, Weltz M . Metastatic thymoma with myasthenia gravis: complete remission with combination chemotherapy. Cancer. 1982; 50(3):419-22. DOI: 10.1002/1097-0142(19820801)50:3<419::aid-cncr2820500306>3.0.co;2-a. View

WILKINS Jr E, Castleman B . Thymoma: a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979; 28(3):252-6. DOI: 10.1016/s0003-4975(10)63114-1. View

Fornasiero A, Daniele O, Ghiotto C, Sartori F, Rea F, Piazza M . Chemotherapy of invasive thymoma. J Clin Oncol. 1990; 8(8):1419-23. DOI: 10.1200/JCO.1990.8.8.1419. View

10.

Lauriola L, Maggiano N, Marino M, Carbone A, Piantelli M, Musiani P . Human thymoma: immunologic characteristics of the lymphocytic component. Cancer. 1981; 48(9):1992-5. DOI: 10.1002/1097-0142(19811101)48:9<1992::aid-cncr2820480914>3.0.co;2-0. View

11.

Chahinian A, Nogeire C, Ohnuma T, Greenberg M, Sivak M, Jaffrey I . Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. Cancer Treat Rep. 1979; 63(11-12):1953-60. View

12.

BERNATZ P, KHONSARI S, HARRISON Jr E, Taylor W . Thymoma: factors influencing prognosis. Surg Clin North Am. 1973; 53(4):885-92. DOI: 10.1016/s0039-6109(16)40093-9. View

13.

Mitrou P, Bergmann L, Tuengerthal S . [Induction of complete remission with adriamycin and cis-platinum in invasive thymoma]. Dtsch Med Wochenschr. 1982; 107(44):1667-70. DOI: 10.1055/s-2008-1070184. View

14.

Pollack A, El-Naggar A, Cox J, Ro J, Sahin A, Komaki R . Thymoma. The prognostic significance of flow cytometric DNA analysis. Cancer. 1992; 69(7):1702-9. DOI: 10.1002/1097-0142(19920401)69:7<1702::aid-cncr2820690710>3.0.co;2-b. View

15.

Stolinsky D, Hum G, JACOBS E, Solomon J, Bateman J . Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms. Cancer Chemother Rep. 1973; 57(4):477-80. View

16.

Klippstein T, Mitrou P, Kochendorfer K, Bergmann L . High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot study. Cancer Chemother Pharmacol. 1984; 13(2):78-81. DOI: 10.1007/BF00257118. View

17.

Marks Jr R, Wallace K, PETTIT H . Radition therpay control of nine patients with malignant thymoma. Cancer. 1978; 41(1):117-9. DOI: 10.1002/1097-0142(197801)41:1<117::aid-cncr2820410118>3.0.co;2-v. View

18.

LEGG M, Brady W . PATHOLOGY AND CLINICAL BEHAVIOR OF THYMOMAS. A SURVEY OF 51 CASES. Cancer. 1965; 18:1131-44. DOI: 10.1002/1097-0142(196509)18:9<1131::aid-cncr2820180914>3.0.co;2-f. View

19.

Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y . Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Am J Pathol. 1988; 133(3):615-22. PMC: 1880827. View

20.

Arriagada R, Bretel J, CAILLAUD J, GARRETA L, GUERIN R, Laugier A . Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol. 1984; 20(1):69-74. DOI: 10.1016/0277-5379(84)90036-1. View